MENU
Showcases Stock ranks Forex

Merck & Company (MRK)
79.86  -0.2 (-0.25%) 11-27 13:02
Open: 80.3 Pre. Close: 80.06
High: 80.68 Low: 79.56
Volume: 4,407,973 Market Cap: 202,048M
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; and Transcenta Holding Ltd. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 80.631 - 81.116 81.116 - 81.476
Low: 78.43 - 79.08 79.08 - 79.563
Close: 79.209 - 80.166 80.166 - 80.877
Stock Technical Analysis
Overall:     
Target: Six months: 99.48
One year: 116.19
Support: Support1: 78.23
Support2: 73.94
Resistance: Resistance1: 85.17
Resistance2: 99.48
Pivot: 80.47
Moving Averages: MA(5): 80.16
MA(20): 79.85
MA(100): 81.25
MA(250): 81.57
MACD: MACD(12,26): 0.11
Signal(12,26,9): 0.08
%K %D: %K(14,3): 16.12
%D(3): 26.16
RSI: RSI(14): 48.81
52-Week: High: 92.64
Low: 65.25
Change(%): -8.2
Average Vol(K): 3-Month: 839689
10-Days: 799215
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

MRK has closed above bottom band by 17.9%. Bollinger Bands are 62.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MRK's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Fri, 27 Nov 2020
First Lady of DR Congo meets Merck Foundation CEO - Big News Network

Fri, 27 Nov 2020
Why Merck (MRK) Is Buying OncoImmune For $425 Million - Pulse 2.0

Fri, 27 Nov 2020
Merck & Company Inc. (new) (MRK) Closes 0.25% Down on the Day for November 27 - Equities.com

Fri, 27 Nov 2020
Merck & Co. Inc. (MRK) Quarterly Performance is -6.71%: Here is the Surprise Factor - The InvestChronicle

Thu, 26 Nov 2020
Merck KGaA partners with Siemens on new plant - MarketWatch

Tue, 24 Nov 2020
Merck Sales Hit Hardest by Pandemic - Yahoo Finance

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 2530.00
Shares Float (M) 2530.00
% Held by Insiders 0.08
% Held by Institutions 75.51
Shares Short (K) 14750
Shares Short Prior Month (K) 10980
Stock Financials
EPS 4.530
Book Value (p.s.) 11.540
Profit Margin 24.33
Operating Margin 32.95
Return on Assets (ttm) 11.3
Return on Equity (ttm) 41.1
Qtrly Rev. Growth 1.2
Gross Profit (p.s.) 13.312
Sales Per Share 18.715
EBITDA (p.s.) 7.514
Qtrly Earnings Growth 54.70
Operating Cash Flow (M) 11040.00
Levered Free Cash Flow (M) 8650.00
Stock Valuation
PE Ratio 17.63
PEG Ratio 1.22
Price to Book value 6.92
Price to Sales 4.27
Price to Cash Flow 18.30
Stock Dividends
Dividend 2.380
Dividend Yield 0.03
Dividend Growth 2.440

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator